[Urological problems in patients with meningomyelocele. Diagnostic studies and management]

R Stein1, A Schröder, R Beetz

  • 1Urologische Klinik und Poliklinik, Klinikum der Johannes Gutenberg Universität, Langenbeck-Strasse 1, Mainz, Germany. Stein@urologie.klinik.uni-mainz.de

Der Urologe. Ausg. A
|October 4, 2007
PubMed

Insights

Management of pediatric meningomyelocele has improved with antimuscarinic agents, clean intermittent catheterization (CIC), and antibiotic prophylaxis for neurogenic bladder. This consensus paper outlines optimized, interdisciplinary care pathways for these complex patients.

Area of Science:

  • Pediatric Urology
  • Neuroscience
  • Rehabilitation Medicine

Context:

  • Meningomyelocele management has evolved significantly since the 1980s.
  • Neurogenic bladder in children presents complex challenges requiring multidisciplinary input.

Purpose:

  • To provide an interdisciplinary consensus on the management of pediatric meningomyelocele.
  • To outline definitions, classifications, and investigation timelines.
  • To detail conservative and surgical treatment options.

Summary:

  • Pharmacotherapy (antimuscarinic agents), clean intermittent catheterization (CIC), and antibacterial prophylaxis have revolutionized neurogenic bladder care.
  • Optimized therapy necessitates collaboration among neonatologists, neurosurgeons, neurologists, pediatricians, urologists, nephrologists, orthopedists, and surgeons.
  • The paper reviews orthopaedic management, latex allergy, bowel management, UTIs, sexuality, fertility, and long-term compliance.

Impact:

  • Establishes a comprehensive framework for the interdisciplinary care of pediatric meningomyelocele.
  • Aims to improve therapeutic outcomes and quality of life for affected children and their families.
  • Provides essential guidance for healthcare professionals involved in managing this condition.